友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。
期刊名
EBioMedicine
EBIOMEDICINE
ISSN / eISSN
2352-3964 / 2352-3964
目标和范围
The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.
研究方向
医学：研究与实验
CiteScore
17.70
查看趋势图
CiteScore 学科排名
| 类别 | 分区 | 排名 |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology - General Biochemistry, Genetics and Molecular Biology | Q1 | #14/212 |
Web of Science 核心合集
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| 类别 (Journal Citation Reports 2023) | 分区 |
|---|---|
| MEDICINE, RESEARCH & EXPERIMENTAL - SCIE | Q1 |
H-index
37
出版国家或地区
Netherlands
出版商
Elsevier BV
年文章数
518
Open Access
YES
通讯方式
RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX
认证评论
2023.3.6 under review
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now